|
|
|
|
Nabi Biopharmaceuticals - Product Publications
PRODUCTS Products Overview PhosLo® Nabi-HB® WinRho SDF® Aloprim™ Plasma Products -----Antibody Plasma -----Products -----Plasma Centers Product Publications Material Safety Data Sheets - Product Publications If you wish to receive a copy of any of the following publications, please contact Nabi Biopharmaceuticals...
|
|
|
Braintree makes lavages and drugs for constipation
announces the nationwide availability of HalfLytely ® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed release tablets).- Press Release - August 5, 2003 Braintree Laboratories, Inc completed transition of the product PhosLo® (Calcium Acetate) to Nabi...
|
|
|
NABI 10-K 03.23.05
When given with food, the calcium acetate in PhosLo combines with dietary phosphorus to form insoluble calcium- phosphate complexes that are eliminated from the body, thereby reducing phosphorus absorption and lowering serum phosphorus levels.
Hence, PhosLo achieves control of serum phosphorus levels as well as calcium- phosphorus product in...
author: bradleylewthwaite
|
|
|
NABI 10-K 03.23.05 page 10
author: bradleylewthwaite
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...
|
|
|
021160_Phoslo Gelcaps & Capsules
Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Phoslo (Calcium Acetate) Capsules & Gelcaps Company:--Braintree Laboratories, Inc
Application No.:--21-160 Approval Date:-4/2/2001 - Approval Letter(s) - Printed Labeling - Medical Review(s) - Chemistry Review(s) - Pharmacology Review(s) - Clinical Pharmacology...
author: Paul Stauffer
|
|
|
Prescription and Over-the-Counter Drug Product List: 8/2003
4 >D> AA + ORTHO MCNEIL PHARM 300MG;60MG N85055 004 AUG DISC >A> @ 300MG;60MG N85055 004 AUG DISC ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA + MALLINCKRODT 500MG/15ML;10MG/15ML N40508 001 AUG 29, 2003 AUG NEWA >D> MIKART 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG CTEC >A> AA 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG...
author: AUTHOR
|
|
|
NDA Approvals for Calendar Year 2001
Braun 5 S 21-Feb-01 21-235 Prozac Weekly Fluoxetine Hydrochloride Eli Lilly 3 S 26-Feb-01 21-169 Reminyl Galantamine Hydrobromide Janssen Research 1 S 28-Feb-01 21-082 Tavist Allergy/Sinus/Headache Acetaminophen/Clemastine Fumarate/Pseudoephedrine Hydrochloride Novartis 4 S 01-Mar-01 21-257 Travatan Travoprost Alcon 1 P 16-Mar-01 21-262 Alphagan P Brimonidine Tartrate Allergan 3 S 16...
author: Brenda Harmon
|
|
|
FDA Drug Approvals List April 2001
- Drug Approvals for April 2001 Definitions and Notes Original New Drug Applications Original Application #: 020949 Approval Date: 30-APR-01 Trade Name: ACCUNEB Chemical Type: 5 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: DEY LABORATORIES INC Active Ingredient(s): ALBUTEROL SULFATE OTC/RX Status: RX Indication(s): For the treatment of asthma-related bronchospasm in...
|
|
|
Prescription and OTC Drug Product List 8/2001
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST PRESCRIPTION DRUG PRODUCT LIST - 21ST EDITION ADDITIONS/DELETIONS FOR RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 8 - AUG 2001 ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL PHRENILIN WITH CAFFEINE AND CODEINE -A- AB AMARIN PHARMS 325MG;50MG;40MG;30MG N74911 001 AUG 22, 2001 AUG NEWA ACETAMINOPHEN;...
|
|
|
http://www.nabi.com/pdf/company_profile.pdf page 2
|
|
|
http://www.nabi.com/pdf/8-K72303.pdf page 4
|
|
|
11
PhosLo ® Capsules (Calcium Acetate) DESCRIPTION: Full Size: Each opaque capsule with a white cap and white body is spin printed in blue ink with "PhosLo ® " printed on the cap and "667 mg" printed on the body
Calcium acetate (PhosLo) when taken with meals, combines with dietary phosphate to form insoluble calcium phosphate which...
author: Administrator
|
|
|
11 page 5
author: Administrator
|
|
|
11 page 1
author: Administrator
|
|
|
Nabi Biopharmaceuticals - Material Safety Data Sheets
PRODUCTS Products Overview PhosLo® Nabi-HB® WinRho SDF® Aloprim™ Plasma Products -----Antibody Plasma -----Products -----Plasma Centers Product Publications Material Safety Data Sheets - Material Safety Data Sheets Nabi Biopharmaceuticals provides the information contained herein in good faith but makes no...
|
|
|
Nabi Biopharmaceuticals - PhosLo, Nabi-HB, WinRho SDF, Aloprim
PATIENTS Patients Overview Product Information -----PhosLo® -----Nabi-HB® -----WinRho SDF® -----Aloprim™ -----Plasma Products Vision, Mission and Values Patients Welcome to Nabi Biopharmaceuticals' patient area.
This patient area is designed to help you learn more about the company's-three marketed...
|
|
|
Nabi Biopharmaceuticals - Pipeline of biopharmaceutical products.
PIPELINE Pipeline Overview StaphVAX® Altastaph™ NicVAX™ Civacir™ Gram-Positive Programs RENS Nabi-HB™ Intravenous HEBIG™ (Europe) Clinical Trials Patent Technologies Pipeline Publications Pipeline Nabi Biopharmaceuticals has a deep pipeline of biopharmaceutical products under development.
PhosLo® ...
|
|
|
Nabi Biopharmaceuticals - focusing on infectious diseases, autoimmune diseases and addictive diseases.
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions.-The company is-focusing on developing products addressing commercial opportunities in-its core business areas: Gram-positive bacterial infections, hepatitis, kidney disease (nephrology), and-nicotine addiction.-There are...
|
|
|
Nabi-Fact sheets (Page 1) page 1
|
|
|
Nabi-Fact sheets (Page 1)
NABI BIOPHARMACEUTICALS' VISION To unlock the power of the human immune system to help people with serious, unmet medical needs.
The company maintains clear commercial synergies between its currently marketed products and products in its research and development pipeline.
Through the marketing of PhosLo ® (calcium acetate), the company has developed an...
|
|
|
PE7-14-05
It has three products on the market: » Nabi- HB ® [Hepatitis B Immune Globulin (Human)] antibody treatment » PhosLo ® (calcium acetate), a treatment for elevated blood phosphate levels associated with kidney failure PHARMACEUTICAL EXECUTIVE 6 JUNE 2005 www.
But I also think it would put us in a position for unparalleled success, because we will be...
|
|
|
PE7-14-05 page 5
|
|
|
NABI 10-K 03.23.05 page 43
author: bradleylewthwaite
|
|
|
NABI 10-K 03.23.05 page 40
author: bradleylewthwaite
|
